ProCE Banner Activity

Focus on People Who Use Drugs: Simplified HCV Screening and Care in Addiction Medicine and Harm Reduction Clinics

Video

On-demand webcast of an expert faculty presentation and discussion on strategies to improve HCV screening and care for people who use drugs.

Released: December 19, 2024

Expiration: December 18, 2025

Share

Faculty

Ronni Marks

Ronni Marks

Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
Patient Advocate
New York, New York

Mark S. Sulkowski

Mark S. Sulkowski, MD, FIDSA, FAASLD

Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Stacey B. Trooskin

Stacey B. Trooskin, MD, PhD, MPH

Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC, in partnership with the Asian Health Foundation, Hepatitis B Foundation, and HealthHCV

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Health HCV

ProCE Banner

Hepatitis B Foundation

ProCE Banner

Disclosure

Primary Author

Ronni Marks,

Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
Patient Advocate
New York, New York

Ronni Marks has no relevant financial relationships to disclose.

Mark S. Sulkowski, MD, FIDSA, FAASLD

Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Mark S. Sulkowski, MD, FIDSA, FAASLD: consultant/advisor/speaker: AbbVie, Gilead, GlaxoSmithKline; data and safety monitoring board: Gilead.

Stacey B. Trooskin, MD, PhD, MPH

Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Stacey B. Trooskin, MD, PhD, MPH: researcher: Gilead Sciences.